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Abstract 
Background 
Transmission of SARS-CoV-2 by bioaerosols is of increasing concern. The enhanced levels of personal 
protective equipment (PPE) and preventative measures to attenuate viral transmission during 
aerosol generating procedures (AGPs) are having a huge impact on healthcare provision. There is no 
quantitative evidence on the number and size of airborne particles produced during AGPs to inform 
risk assessments. 
Methods 
Real-time, high-resolution environmental monitoring was conducted in ultraclean ventilation 
operating theatres. Continuous sampling with an optical particle sizer allowed characterization of 
aerosol generation within the airway management zone during endotracheal intubation and 
extubation for urgent orthopaedic trauma or neuro-surgery. 
Results 
Aerosol monitoring showed a very low background particle count allowing resolution of the 
transient airborne particle plume produced by reference volitional coughs (maximum concentration, 
1,690±140 particles.L
-1
,n=38). By comparison, endotracheal intubation including mask ventilation 
produced negligible quantities of aerosolized particles (maximum concentration, 80±10 L
-1
,n=14, 
P<0·001 vs cough). Extubation, particularly when the patient coughed, produced a detectable 
aerosol plume but with a smaller number of particles (<25%) than a volitional cough. 
Conclusions 
Using a volitional cough as a reference we have been able to produce a relative risk ranking for 
endotracheal intubation and extubation as potential AGPs. The study does not support the 
assignation of endotracheal intubation by direct laryngoscopy with manual ventilation as an AGP. 
Extubation does generate aerosols, particularly if the patient coughs, but these are weaker than a 
standard reference. These findings indicate the need for a reappraisal of guidance on PPE for AGPs. 
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Introduction 
The SARS-CoV-2 virus and associated COVID-19 pandemic have had an unprecedented impact on 
global health and the world economy. Drastic interventions to limit transmission have been 
introduced worldwide such as physical distancing and the use of personal protective equipment 
(PPE). These strategies are based in part on existing knowledge from similar respiratory pathogens 
such as SARS-CoV-1. 
Respiratory secretions have a high SARS-CoV-2 viral load and are believed to be the main source for 
person-to-person transmission.
1
 Coughing and sneezing atomize respiratory secretions into particles 
with different aerodynamic properties according to size; particles greater than 20µm in diameter are 
conventionally defined as droplets and tend to follow a ballistic trajectory. These droplets can either 
directly infect a susceptible individual within close proximity (<1m) or may settle on nearby surfaces 
(fomites) where viable virus can exist for up to 72 hours on surfaces.
2
 Droplet and contact 
transmission are considered the predominant modes of transmission of SARS-CoV-2, providing the 
rationale for physical distancing and hand hygiene to prevent spread. 
Concern is growing about the role aerosolized viral transmission plays in COVID-19.
3,4
 Aerosolized 
particles (<5µm in diameter) may transmit infection by transiting the full extent of the respiratory 
tract to be deposited in the alveoli. The importance of airborne SARS-CoV-2 transmission relative to 
the droplet and contact modes remains unclear and the optimum methods of preventing bioaerosol 
transmission are debated.
5–8
 To minimize airborne transmission of SARS-CoV-2 to healthcare 
workers, specific patient care activities have been designated as Aerosol Generating Procedures 
(AGPs) with recommended levels of enhanced PPE. The evidence for this designation is largely based 
on retrospective cohort and case-control studies of transmission during the SARS pandemic; a 
systematic review of these studies categorized the quality of available evidence as ‘very low’ and not 
suitable for extrapolation to other settings.
9,10
 There is no quantitative evidence of increased aerosol 
generation from AGPs. Aerosol sampling in the vicinity of patients with H1N1 influenza during AGPs 
did not clearly demonstrate an increased risk above background of detecting virus RNA in the air 
(including data from intubations).
11
 
Tracheal intubation and extubation, manual ventilation and respiratory tract suctioning are AGPs 
undertaken regularly by anaesthetists in operating theatres, exposing healthcare workers to 
potential airborne transmission of SARS-CoV-2.
9,12,13
 The World Health Organization has and many 
other governmental organization including Public Health England have recommended that such 
AGPs are performed in enhanced PPE consisting of a respirator style facemask, fluid resistant gown, 
long gloves and a face shield or visor.
13
 The evidence base for these guidelines is weak and the 
magnitude of risk for each AGP is unknown.
12
 There is a complete absence of evidence regarding the 
quantity of aerosol produced by AGPs.  
Wearing enhanced levels of PPE has consequences for the conduct of clinical practice. The use of 
PPE for AGPs increases stress, anxiety and discomfort of healthcare workers, poses challenges for 
teamworking, impairs communication and these collectively have the potential to increase the risk 
of clinical errors. Additionally, methods introduced to mitigate the risks posed by bioaerosols have 
reduced operating theatre turnover, decreased hospital productivity and increased waiting times for 
urgent, elective and cancer surgery. A further important consideration relates to the cost and limited 
supply of PPE which has to be targeted to the healthcare workers at highest risk of viral infection. 
The enhanced PPE recommendations are based on the assumption that AGPs pose a higher risk of 
aerosolized viral transmission than exposure to a patient who is coughing. There is a comparatively 
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large evidence base around aerosolized particles generated by coughing with sizes ranging from 
visible droplets to submicron particles.
14–16
 When AGPs are placed in the context of a cough it is 
worth reflecting that in the case of intubation, the objective of the anaesthetic team is to avoid the 
generation of a cough - a sign of inadequate depth of anaesthesia and / or neuromuscular blockade. 
Given the uncertain balance of potential risks and benefits associated with the protective strategies 
put in place to limit viral transmission, it is important to quantitatively assess the degree to which 
individual AGPs generate aerosolized particles.  
We aimed to quantitate particle emission in real-time during endotracheal intubation and 
extubation, using particle analysis instruments in a working surgical operating theatre environment. 
We used a volitional cough a reference comparison. 
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Methods 
An environmental monitoring study was conducted to quantitate the airborne particle size 
distribution and particle number concentration produced by AGPs in two operating theatres in a UK 
teaching hospital (North Bristol NHS Trust). Ethical approval for the study was given by the Faculty of 
Life Science and Science Research Ethics Committee at University of Bristol (ref: 105203). As this was 
an observational study, the anaesthetic and theatre team undertook their normal practice during 
airway management. 
The operating theatres have an ultraclean, laminar flow ventilation system (EXFLOW 32, Howorth Air 
Technology) with a HEPA filtered air supply rate of 1200m
3
.s
-1
. Temperature in theatres was set to 
20˚C and humidity between 40-60%. This ventilation system has a canopy, which is the ‘clean zone’ 
where surgical procedures are performed; the air circulation velocity is 0·2 m.s
-1
 at 1 m above the 
floor in the canopy. All aerosol recordings were performed in the ‘clean zone’ canopy. 
A lightweight, portable Optical Particle Sizer (OPS, TSI Incorporated, model 3330) was used which 
samples air at 1 L min
-1
 and detects particles by laser optical scattering. The OPS reports the particle 
number concentration and size distribution within the optical diameter range 300 nm to 10 µm with 
a time resolution of 1s.  
A sampling funnel was 3D printed (RAISE3D Pro2 Printer, 3DGBIRE) with a maximal diameter of 150 
mm, cone height of 90 mm with a 10 mm exit port. A conductive silicone sampling tube with a length 
of 2 m and internal diameter 4·8 mm (3001788, TSI) was connected to the OPS to sample particles in 
the ‘airway management zone’ - the region between the patient and healthcare worker performing 
the AGP.  
In the ultraclean theatre environment, it was possible to reliably detect a standard volitional cough 
(by JB) at a distance of 0·5 m between the participant and the sampling funnel, reporting a size 
distribution in keeping with previous aerosol studies.
17
 Sampling at 0·5 m represents a typical 
distance from the face of healthcare workers involved in airway management to the patient’s 
mouth. Nonetheless, the sampling funnel was handheld to ensure it could be quickly removed from 
the airway management zone in case of clinical need (this was not needed in the course of the 
study). All healthcare workers, and members of the investigating team, wore enhanced PPE for 
AGPs. 
All anaesthetic inductions followed a conventional sequence with pre-oxygenation, intravenous 
induction by administration of anaesthetic and muscle relaxant, manual ventilation, direct 
laryngoscopy and intubation of the trachea followed by inflation of the endotracheal tube cuff which 
was the reference end point of intubation. This whole sequence typically lasted 3-4 minutes and a 
five-minute period before cuff up was analysed. 
For extubation, the level of anaesthesia was lightened, spontaneous breathing allowed to 
recommence, the oropharynx suctioned before the endotracheal tube cuff was deflated, the patient 
extubated, and the airway patency ensured as necessary with co-application of an anaesthetic 
facemask before application of a Hudson mask. The reference event for extubation was ETT cuff 
deflation (releasing the seal on the airway) and three minutes before and up to 2 minutes after cuff 
down was recorded. 
Airway management events were recorded contemporaneously using a time stamp application 
(Emerald Sequoia LLC): 
Analysis 
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Data were exported from the TSI optical particle sizer, processed in the TSI Aerosol Instrument 
Manager software, and analysed in Origin Pro (Originlab) and Prism v8 (Graphpad). Comparisons 
were made between aerosol generating events with unpaired t-tests with significance level at 
P<0·05. All data are presented as mean±SEM or ±95%CI unless otherwise indicated. 
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Results 
Environmental aerosol monitoring was conducted over a 3-week period during operating lists for 
orthopaedic trauma and neurosurgical emergencies. Recordings within the airway management 
zone were performed during 7 all-day theatre sessions across 3 theatres with 19 intubations and 14 
extubations. The conduct of anaesthesia was left at the discretion of the anaesthetist (who ranged in 
experience from junior trainee to senior consultant). 
Initial environmental aerosol monitoring recordings showed the ultraclean, laminar flow ventilation 
and air filtration system produced a very low background of aerosol particles (averaging 0·4 L
-1 
when 
the theatre is empty, and 3·4 L
-1
 
 
when the theatre is in use but no AGPs are in progress). By 
comparison background recordings in a nearby non-laminar flow operating theatre showed aerosol 
particle counts that were ~4 orders of magnitude greater (15x10
3
 L
-1
). 
Standard volitional coughs showed a characteristic profile with a rapid and transient jet of 
expectorated particles. The large majority of the particles were <1µm diameter with a concentration 
~300x background when sampled at 0·5m distance. The peak aerosol concentration, 1,310±150 
particles L
-1
 (n=38 coughs), typically occurred 2 seconds after the cough was registered with an 
average total of 134±13 particles summed over 12 seconds (Figure 1A). The spike in aerosol particle 
count decayed back to baseline with a time constant of ~2·7 seconds. Of note, although we 
conducted our monitoring in an ultraclean ventilation canopy, the cessation of flow of the 
ventilation system (0·2 m.s
-1
) did not alter the magnitude of the particle plume (On: 164±27 vs Off: 
153±27 particles, ns, n=9 per group). 
Monitoring during the entire period of intubation showed very little increase in aerosol generation 
above background levels within the airway management zone. The average number of particles 
detected in a 5 minute period before cuff inflation was 7±2 (n=14), compared to a background in the 
empty theatre of ~2 particles per 5 minute period (Figure 1B). An equivalent series of measurements 
during intubation in the absence of laminar flow produced a similar low particle count (6±1, n=5, ns). 
The average concentration of particles recorded during the intubation period (0·8 L
-1
) was around 
three orders of magnitude lower than the average level recorded during reference coughs (750 
particles L
-1
). These recording periods always included manual mask ventilation, as well as episodes 
of airway suction, sometimes also requiring several attempts at laryngoscopy/intubation.
 
Extubation produced a relatively low average concentration of aerosolized particles (21±6 L
-1
, n=10, 
Figure 1C) which was ~35 fold lower than that seen during a volitional cough (750 particles L
-1
). 
However, given that monitoring during the extubation period was surveying over 5 minutes rather 
than 12 seconds this translated to a similar total number of particles (100±28 (n=10) particles over 
the period of extubation compared to 134±13 with a single cough, ns). It was noted that several of 
the extubations included a cough (often just after cuff deflation) that was timestamped and 
detected as an aerosol generating event (n=4/10, Figure 1C). These extubation coughs produced a 
similar size distribution of aerosolized particles to the standard reference coughs (Figure 1D) 
although they were always smaller in magnitude (33±4 particles per cough – n=5) equating to less 
than 25% of the particles produced by an average volitional cough (Figure 1E).  
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Discussion 
By conducting aerosol sampling in an ultraclean theatre environment during routine clinical practice 
we have been able to produce a unique, quantitative dataset documenting the aerosols produced by 
volitional coughs compared to common anaesthetic AGPs. These findings demonstrate the process 
of endotracheal intubation is associated with a very low risk of aerosol generation. Even when 
considering the total period of anaesthetic induction including manual ventilation and airway 
instrumentation (~5 minutes), the total particle count overall is still less than 5% of that associated 
with a single volitional cough. The conduct of a standard anaesthetic induction is designed to obtund 
airway reflexes and is accompanied by a muscle relaxant to ensure that the anaesthetized patient 
can neither breathe nor co-ordinate their upper airway musculature (vocal cords). This 
choreographed sequence makes the chance of an active respiratory event like a cough remote. The 
fact that we could only detect very low levels of aerosol indicates that slower gas movements, such 
as during manual ventilation or indeed with expiration due to passive elastic lung recoil when the 
airway is opened for laryngoscopy, generates barely detectable levels of airborne particles. It is also 
worth noting that these intubations reflected typical clinical practice by anaesthetists with a range of 
experience and were not all straightforward, providing further reassurance regarding the low level 
of aerosol generation. 
A more nuanced picture is seen with extubation where although the overall concentration of aerosol 
was less than a single cough nonetheless the cumulative number of airborne particles (over a 5 
minute period) was of the same order of magnitude to that seen with a single volitional cough. 
Indeed, a cough event was noted in 50% of extubations and this was detected as an aerosol plume. 
These extubation coughs were weaker than volitional coughs (~25%) and transient with aerosol only 
detectable for 5-10 seconds. A recognized risk during emergence from anaesthesia is that the upper 
airway reflexes may be obtunded by residual anaesthesia or muscle relaxant placing the patient at 
risk of aspiration. Hence a cough is often taken as a positive sign as it signals the return of these 
reflexes enabling a patient to clear secretions. The risk of aerosolized particles could be reduced by 
the expedient of positioning by the anaesthetist behind the patient’s head and thus out of the direct 
stream of any potential cough plume (as is normal practice). Coughing on extubation can also 
potentially be avoided by modifying the anaesthetic technique in higher risk patients. 
Our results for intubation are at odds with previous retrospective evidence which was used to 
designate intubation an AGP
9,10
. These studies found an association between acquiring SARS and 
being in the room during intubation but without measuring any aerosol generation. We postulate 
that other mechanisms of transmission, such as direct exposure to respiratory secretions or fomites, 
could account for spread rather than aerosolized virus. Extubation in this study was often associated 
with coughs that generate a detectable aerosol, but these were weaker than a volitional cough. On 
this basis it seems hard to justify its designation as a high risk AGP, nonetheless appropriate 
precautionary measures are needed, especially in higher risk cases such as COVID positive patients. 
Given that a fluid resistant surgical mask is deemed an appropriate level of PPE for close exposure to 
a confirmed COVID-19 positive patient in current UK guidelines
13
, then use of respirator masks does 
not seem necessary for intubation and manual ventilation which are currently defined as AGPs and 
should be considered (rather than mandated) as part of a risk mitigation strategy for extubation of 
higher risk patients.  
In conclusion this study indicates that the process of endotracheal intubation produces a barely 
recordable increase in aerosol and should not be defined as an aerosol generating procedure. When 
a patient coughs during endotracheal extubation, a measurable particle plume is produced but the 
aerosol is smaller than a volitional cough. These results should help inform future PPE guidelines, 
 8
potentially reducing unnecessary usage of respirator type face masks whilst saving stocks for verified 
high risk AGPs. 
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Figure 1 Aerosol measurement during intubation and extubation in operating theatre environment 
A. Temporal profile of aerosol generation from volitional coughs. Individual recordings (n=38) 
represented on heat map showing the total number particle concentration over time. Average time 
course plotted (mean±95%CI) showing a peak after 2 seconds and a decay back to baseline within 15 
seconds. 
B. Profile of the total number concentration of aerosol detected during the critical phase of 
intubation (arrow at 300s marks completion of intubation with cuff up). When plotted on the same 
scale as the cough (B) then this looks like a flat line and when shown on a ten-fold expanded scale 
below it can be seen that it is not significantly different to baseline (mean±95%CI). 
C. Extubation recordings from each patient (n=10) plotted as the average and individually as rows on 
heat map of number concentration of particles (lower, on same scale as B) which showed sporadic 
aerosol events (red, ringed) after cuff deflation set on a low baseline level of particles. The average 
concentration of aerosol was low overall (shown above as mean±95%CI). 
D. The extubation cough events (n=5) had a similar aerosol particle size distribution to volitional 
coughs with a predominance of diameters <1µm (mean±SD). 
E. The extubation coughs were of a smaller magnitude than the volitional coughs (particle number 
concentration profile shown overlaid, mean±95%CI). 
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